Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerEvan Rosenbaum, Sandra P. D’Angelo, Mary Lou Keohan et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 58
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, William D. Tap, Philip Jonsson et al.|JCO Precision Oncology|2020Cited by 44
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical OutcomeEvan Rosenbaum, Sandra P. D’Angelo, Kenneth Seier et al.|Clinical Cancer Research|2020Cited by 26
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K. Slotkin, William D. Tap, Audrey Mauguen et al.|JCO oncology advances.|2025Cited by 3
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapyBenjamin A. Nacev, Sandra P. D’Angelo, Martina Bradić et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 1